NCT06810492 2025-03-17
The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment
Hubei Cancer Hospital
Phase NA Not yet recruiting
Hubei Cancer Hospital
Baylor Breast Care Center
GlaxoSmithKline
Fudan University